TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2,585 Cr | ₹3,266 Cr | ₹2,368 Cr | ₹1,803 Cr | ₹2,005 Cr |
What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹2,585 Cr |
| Mar2024 | ₹3,266 Cr |
| Mar2023 | ₹2,368 Cr |
| Mar2022 | ₹1,803 Cr |
| Mar2021 | ₹2,005 Cr |
How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,585 Cr | -20.85 | |
| Mar2024 | ₹3,266 Cr | 37.92 | |
| Mar2023 | ₹2,368 Cr | 31.34 | |
| Mar2022 | ₹1,803 Cr | -10.09 | |
| Mar2021 | ₹2,005 Cr | - | |
Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹147,907.9 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
| MANKIND PHARMA | ₹89,250.5 Cr | -3.7% | 3.8% | -5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0% |
10% |
45.6% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses